INDOMETHACIN (IND) ATTENUATES RENAL TOXICITY AND ADVERSE METABOLIC EFFECTS OF SYSTEMIC INTERLEUKIN-2 (IL2) ADMINISTRATION IN PATIENTS WITH METASTATIC CANCER
D. Rubinger et al., INDOMETHACIN (IND) ATTENUATES RENAL TOXICITY AND ADVERSE METABOLIC EFFECTS OF SYSTEMIC INTERLEUKIN-2 (IL2) ADMINISTRATION IN PATIENTS WITH METASTATIC CANCER, Journal of the American Society of Nephrology, 5(3), 1994, pp. 403-403